# 04. Release Risk Assessment

**Release Version:** v1.0.0  
**Methodology:** Failure Mode and Effects Analysis (FMEA) applied under FDA CSA Guidance  

---

## 1. High-Risk Functions Assessed for Release
In accordance with Computer Software Assurance (CSA), automated testing is concentrated on high-risk functions with direct impact on device safety, record integrity, and regulatory compliance:

1. **Cross-Tenant Access Bleed:** Addressed via `requireOrgAuth` query scoping. Verified in `tests/complaint-multi-tenant-isolation.test.ts`.
2. **Unauthorized Record Modification:** Addressed via closed-record immutability guards. Verified in `tests/closed-complaint-modification-protection.test.ts`.
3. **Audit Trail Failure:** Addressed via transactional audit emission on all mutations. Verified in `tests/audit-history-view.test.ts`.
4. **Forged or Repudiated E-Signatures:** Addressed via dual-credential re-authentication and SHA-256 hash snapshotting. Verified in `tests/e-signature-recording.test.ts`.
5. **Reportable Incident Closure without MIR:** Addressed via pre-closure validation blocking. Verified in `tests/mir-subfolder-lifecycle-and-closure.test.ts`.

**Conclusion:** All critical and high-risk failure modes have verified mitigations. Residual platform risk is **ACCEPTABLE**.
